BOOK
Anticoagulation Therapy: A Clinical Practice Guide
A Clinical Practice Guide
Editors: Nutescu, Edith A. | Gulseth, Michael P.
(2018)
Additional Information
Book Details
Abstract
Anticoagulation Therapy has become the go-to resource for pharmacists who treat and manage the millions of patients on anticoagulants in both inpatient and outpatient settings. The second edition of this quick reference will continue with its heavy reliance on tables and bulleted lists. The second edition will feature new chapters on mechanical devices and considerations in special populations. The pioneering chapter on anticoagulation reversal will be divided into two chapters with one focusing on agents and one on patient considerations. Also new for this edition: 5 new chapters, 2 new appendixes, 3 updated appendixes.
Dager is a recipient of multiple teaching and mentoring awards including the American College of Clinical Pharmacy Best Practice Award. He is a reviewer and editorial board member for multiple medical journals including Chair of the Editorial Advisory Board panel on anticoagulation for the Annals of Pharmacotherapy. He is also a site coordinator for the ASHP Foundation anticoagulation preceptorship, has authored over 60 journal articles and over 10 book chapters, and is an active lecturer. His research has focused on ways to optimize the safe and effective use of medications in the midst of challenges that arise in patient care.
Michael P. Gulseth, PharmD, BCPS is Program Director for Anticoagulation Services, Department of Pharmaceutical Services, Sanford USD Medical Center, Sioux Falls, SD. Dr. Gulseth received his Doctor of Pharmacy degree in 1999 from North Dakota State University in Fargo, ND. He completed residency training at United Hospital in St. Paul, MN. He is lead author and editor of Managing Anticoagulation Patients in the Hospital: the Inpatient Anticoagulation Service, published in 2007 by the American Society of Health-System Pharmacists.
Gulseth is a member of the Editorial Advisory Board of the American Journal of Health-System Pharmacy. Dr. Gulseth is an active member of several professional pharmacy organizations, including ASHP, the Minnesota Society of Health-System Pharmacists, the South Dakota Society of Health-System Pharmacists, and the American College of Clinical Pharmacy. His research interests include evaluation of antithrombotic therapies in the inpatient setting and evaluation of the benefits of pharmacist managed inpatient anticoagulation services.
Edith A. Nutescu, PharmD, MS CTS, FCCP is Professor and Head, Department of Pharmacy Practice, University of Illinois at Chicago, College of Pharmacy. She earned her PharmD degree with high honors at the University of Illinois at Chicago College of Pharmacy. After graduation, she went on to complete an ASHP-accredited pharmacy practice residency at Lutheran General Hospital–Advocate Health Care and a primary care specialty residency at the University of Illinois at Chicago Medical Center. As a clinician and educator, she has contributed extensively to the care of patients and the education of students and healthcare providers on topics related to vascular diseases and antithrombotic medication safety.
Nutescu was honored with the 2010 Distinguished Service Award from the American Society of Health-System Pharmacists, where she has been an active member. She has served on the Home, Ambulatory, and Chronic Care Practitioners Programming Committee and on the Section of Clinical Specialists and Scientists Committee on Nominations. She has been a presenter and meeting programming associate for several scientific and clinical programs at ASHP Midyear Meetings. She has also been active on the Illinois Council of Health-System Pharmacy. Dr. Nutescu was the only pharmacist member nominated to serve on the Steering Committee for the National Quality Forum and the Joint Commission on the Accreditation of Healthcare Organizations–National Consensus Standards for the Prevention and Care of Venous Thrombosis. She has been recognized as a Fellow of the American College of Clinical Pharmacy and is the 2009 recipient of the American College of Clinical Pharmacy’s Clinical Practice Award, one of the highest distinctions awarded in clinical pharmacy.
Table of Contents
Section Title | Page | Action | Price |
---|---|---|---|
Dedication | 3 | ||
Contents | 5 | ||
Contributing Editors | 7 | ||
Contributors | 7 | ||
Preface | 11 | ||
Acknowledgments | 13 | ||
Abbreviations | 15 | ||
Part I. Anticoagulation Medication Management | 21 | ||
Ch 1. Introduction to Anticoagulation Management | 23 | ||
Ch 2. Warfarin | 33 | ||
Ch 3. Unfractionated Heparin | 55 | ||
Ch 4. Low Molecular Weight Heparin and Fondaparinux | 85 | ||
Ch 5. Parenteral Direct Thrombin Inhibitors | 105 | ||
Ch 6. Thrombolytic Considerations When Used with Anticoagulants | 127 | ||
Ch 7. Direct Oral Anticoagulants | 151 | ||
Ch 8. Anticoagulation Reversal: Part I—Pharmacology of Agents Used for Reversal | 183 | ||
Ch 9. Anticoagulation Reversal: Part II—Clinical Application | 203 | ||
Ch 10. Transitions in Care—Periprocedural Bridging and Transitions Between Agents | 243 | ||
Ch 11. Considerations in Special Populations | 271 | ||
Part II. Conditions Requiring Anticoagulation Therapy | 301 | ||
Ch 12. Venous Thromboembolism Prevention | 303 | ||
Ch 13. Venous Thromboembolism Treatment | 333 | ||
Ch 14. Atrial Fibrillation | 367 | ||
Ch 15. Acute Coronary Syndromes | 383 | ||
Ch 16. Prosthetic Heart Valves | 413 | ||
Ch 17. Mechanical Circulatory Support Devices | 425 | ||
Ch 18. Heparin-Induced Thrombocytopenia | 443 | ||
Ch 19. Pregnancy | 469 | ||
Ch 20. Pediatrics | 501 | ||
Part III. Practical Measuring, Monitoring, and Coagulation Laboratory\r\nInsights | 525 | ||
Ch 21. Coagulation Laboratory Considerations | 527 | ||
Ch 22. Thrombophilias | 569 | ||
Part IV. Essentials for Practice Success | 595 | ||
Ch 23. Models and Standards of Anticoagulation Care Delivery | 597 | ||
Ch 24. Regulatory and Practice Resources | 625 | ||
Appendixes | 635 | ||
Appendix A. Coagulation Cascade | 637 | ||
Appendix B. Agents Implicated in Drug-Induced Thromboembolic Diseases | 638 | ||
Appendix C. Nutrition Influence on Anticoagulation | 643 | ||
Appendix D. Anticoagulants in Management of Ischemic Stroke or Transient Ischemic Attacks | 645 | ||
Appendix E. Citrate Anticoagulation | 647 | ||
Appendix F. Examples of Available Bleeding Definitions | 649 | ||
Appendix G. Types of CNS Hemorrhage | 651 | ||
Appendix H. Disseminated Intravascular Coagulation | 652 | ||
Appendix I. Nondrug Causes of Thrombocytopenia | 653 | ||
Appendix J. Drug-Related Causes of Thrombocytopenia | 654 | ||
Appendix K. Examples of Transfusion-Related Reactions | 657 | ||
Appendix L. Considerations for Transitioning from aPTT to Anti-Xa to Manage Heparin Therapy | 658 | ||
Appendix M. PIONEER AF-PCI | 661 | ||
Appendix N. Betrixaban APEX Trial | 662 | ||
Index | 663 |